These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37082750)

  • 1. Biochemical Discovery, Intracellular Evaluation, and Crystallographic Characterization of Synthetic and Natural Product Adenosine 3',5'-Cyclic Monophosphate-Dependent Protein Kinase A (PKA) Inhibitors.
    Wilson BAP; Li N; Martinez Fiesco JA; Dalilian M; Wang D; Smith EA; Wamiru A; Shah R; Goncharova EI; Beutler JA; Grkovic T; Zhang P; O'Keefe BR
    ACS Pharmacol Transl Sci; 2023 Apr; 6(4):633-650. PubMed ID: 37082750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
    Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS
    Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of oocyte maturation and cumulus expansion in the mouse oocyte-cumulus cell complex by site-selective analogs of cyclic adenosine monophosphate.
    Downs SM; Hunzicker-Dunn M
    Dev Biol; 1995 Nov; 172(1):72-85. PubMed ID: 7589815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit.
    Akamine P; Madhusudan ; Brunton LL; Ou HD; Canaves JM; Xuong NH; Taylor SS
    Biochemistry; 2004 Jan; 43(1):85-96. PubMed ID: 14705934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-Chloroadenosine mediates 8-chloro-cyclic AMP-induced down-regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP-independent mechanism.
    Lange-Carter CA; Vuillequez JJ; Malkinson AM
    Cancer Res; 1993 Jan; 53(2):393-400. PubMed ID: 8380255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase A inhibition induces EPAC-dependent acrosomal exocytosis in human sperm.
    Itzhakov D; Nitzan Y; Breitbart H
    Asian J Androl; 2019; 21(4):337-344. PubMed ID: 30632486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth.
    Grassi ES; Dicitore A; Negri I; Borghi MO; Vitale G; Persani L
    Endocrine; 2017 May; 56(2):388-398. PubMed ID: 27460006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent inhibition of IL-5 from human T lymphocytes is not mediated by the cAMP-dependent protein kinase A.
    Staples KJ; Bergmann M; Tomita K; Houslay MD; McPhee I; Barnes PJ; Giembycz MA; Newton R
    J Immunol; 2001 Aug; 167(4):2074-80. PubMed ID: 11489990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-chloroadenosine 3',5'-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts.
    Noguchi K; Murata T; Cho-Chung YS
    Eur J Cancer; 1998 Jul; 34(8):1260-7. PubMed ID: 9849489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of type I protein kinase A to lipid rafts is required for platelet inhibition by the 3',5'-cyclic adenosine monophosphate-signaling pathway.
    Raslan Z; Magwenzi S; Aburima A; Taskén K; Naseem KM
    J Thromb Haemost; 2015 Sep; 13(9):1721-34. PubMed ID: 26176741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
    Schiller M; Verrecchia F; Mauviel A
    Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analyses of the PKA RIIβ holoenzyme containing the oncogenic DnaJB1-PKAc fusion protein reveal protomer asymmetry and fusion-induced allosteric perturbations in fibrolamellar hepatocellular carcinoma.
    Lu TW; Aoto PC; Weng JH; Nielsen C; Cash JN; Hall J; Zhang P; Simon SM; Cianfrocco MA; Taylor SS
    PLoS Biol; 2020 Dec; 18(12):e3001018. PubMed ID: 33370777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.
    Russo I; Doronzo G; Mattiello L; De Salve A; Trovati M; Anfossi G
    Thromb Res; 2004; 114(4):265-73. PubMed ID: 15381390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanisms.
    Lucchi S; Calebiro D; de Filippis T; Grassi ES; Borghi MO; Persani L
    PLoS One; 2011; 6(6):e20785. PubMed ID: 21695205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD).
    Banales JM; Masyuk TV; Gradilone SA; Masyuk AI; Medina JF; LaRusso NF
    Hepatology; 2009 Jan; 49(1):160-74. PubMed ID: 19065671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N4-monobutyryl-cCMP activates PKA RIα and PKA RIIα more potently and with higher efficacy than PKG Iα in vitro but not in vivo.
    Wolter S; Dove S; Golombek M; Schwede F; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1163-75. PubMed ID: 25192685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugging the Undruggable: How Isoquinolines and PKA Initiated the Era of Designed Protein Kinase Inhibitor Therapeutics.
    Lorenz R; Wu J; Herberg FW; Taylor SS; Engh RA
    Biochemistry; 2021 Nov; 60(46):3470-3484. PubMed ID: 34370450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of cAMP-dependent protein kinase type I inhibits rat natural killer cell cytotoxicity.
    Torgersen KM; Vaage JT; Levy FO; Hansson V; Rolstad B; Taskén K
    J Biol Chem; 1997 Feb; 272(9):5495-500. PubMed ID: 9038153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC).
    Chen H; Wild C; Zhou X; Ye N; Cheng X; Zhou J
    J Med Chem; 2014 May; 57(9):3651-65. PubMed ID: 24256330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.